- ►diabetesjournals.org V Kolavennu, L Zeng, H Peng, Y Wang, FR … - Diabetes, 2008 - Am Diabetes Assoc OBJECTIVE—RhoA, a small GTPase protein, and its immediate downstream target,
Rho kinase (ROCK), control a wide variety of signal transduction pathways.
Recent studies have shown that fasudil, a selective ROCK inhibitor, may ... Cited by 16 - Related articles - BL Direct - All 4 versions
- ►physiology.org [PDF] E Sugaru, T Nakagawa, M Ono-Kishino, J … - American Journal of Physiology- Renal Physiology, 2006 - Am Physiological Soc 45 articles, 21 of which you can access free at: This article cites
http://ajprenal.physiology.org/cgi/content/full/290/4/F813#BIBL ... 3 other
HighWire hosted articles: This article has been cited by Cited by 14 - Related articles - BL Direct - All 6 versions
M KOBAYASHI, H KIMURA, J LIAO, M ABE, … - Analytical Sciences, 2003 - J-STAGE Page 1. Type IV collagen is one of the principal components of renal
extracellular matrix; it is released from the glomerular and ... Cited by 12 - Related articles - BL Direct - All 4 versions
E Sugaru, T Nakagawa, M Ono-Kishino, J … - Nephron Exp Nephrol, 2007 - content.karger.com Background/Aims: Diabetic nephropathy is the main cause of end-stage renal
disease. Previously we have demonstrated that SMP-534 (an antifibrotic agent)
prevents the development of diabetic nephropathy in db/db mouse and that ... Cited by 6 - Related articles - BL Direct - All 6 versions
- ►sherbornegibbs.com [PDF] O Deyneli, D Yavuz, A Velioglu, H Cacma, N … - Journal of Renin-Angiotensin-Aldosterone System, 2006 - jra.sagepub.com Abstract Angiotensin-converting enzyme (ACE) inhibitors may reduce urinary
albumin excretion (UAE) by decreasing glomerular pressure and increasing
glomerular charge selectivity through preservation of glycosaminoglycans. ... Cited by 5 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org MP Cohen, CW Shearman, GT Lautenslager - Diabetes care, 2001 - Am Diabetes Assoc OBJECTIVE—Whereas increased urinary excretion of type IV collagen, which is
believed to reflect renal overproduction of this extracellular matrix protein in
early diabetic nephropathy, has been confirmed in several studies, ... Cited by 5 - Related articles - BL Direct - All 7 versions
E Sugaru, T Nakagawa, M Ono-Kishino, J … - Am J Nephrol, 2006 - content.karger.com Background/Aims: Diabetic nephropathy is now the most common cause of end-stage
renal disease. It is also clear that the current therapy, angiotensin II
blockage, cannot prevent the progression of diabetic nephropathy. We had ... Cited by 4 - Related articles - BL Direct - All 5 versions
N Takamatsu, H Abe, T Tominaga, K Nakahara, … - BMC Nephrology, 2009 - biomedcentral.com Norimichi Takamatsu (takamatu@clin.med.tokushima-u.ac.jp) Hideharu Abe
(abeabe@clin.med.tokushima-u.ac.jp) Tatsuya Tominaga (tatsuya@medsci.tokushima-u
.ac.jp) Kunihiko Nakahara (knakahara@hubitgenomix.com) Yumi Ito (yito@ ... Related articles - View as HTML
